Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography

Dy-DOTA integrated mesoporous silica nanoparticles as promising ultrahigh field magnetic resonance imaging contrast agents

Integrating Dy-DOTA motifs into mesoporous silica nanoparticle scaffolds generates remarkable ultrahigh field T2 relaxivities for a well-defined and tailorable contrast agent, attributed to enhanced Curie outer-sphere contributions as supported by simulation.

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene glycol)/Arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres as an Enhanced T1 Magnetic Resonance Imaging Contrast Agent

A new strategy for designing contrast agents (CAs) based on geometrical confinement will become a competent way to improve the relaxivity of CAs. Herein, a magnetic resonance imaging (MRI) nanoconstruct is fabricated through loading Gd₂O₃ nanoparticles into mesoporous carbon nanospheres, followed by conjugation of poly(ethylene glycol) (PEG) and the c(RGDyK) peptide (Gd₂O₃@OMCN-PEG-RGD), which could prolong the blood circulation half-life as well as improve the tumor-targeting ability. As a result, the Gd₂O₃@OMCN-PEG-RGD exhibits an outstandingly high relaxivity ( r₁ = 68.02 mM^-1 s^-1), which is ∼5.3 times higher than that of Gd₂O₃ nanoparticles ( r₁ = 12.74 mM^-1 s^-1). Afterward, both the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test and H&E staining show that the Gd₂O₃@OMCN-PEG-RGD has wonderful biocompatibility in vitro and in vivo. Moreover, the in vivo MR images indicate that the Gd₂O₃@OMCN-PEG-RGD could accumulate in the tumor region more rapidly than Gd₂O₃@OMCN-PEG. This study presents a facile method to fabricate an MRI CA with excellent T₁ contrast ability based on geometrical confinement and excellent biocompatibility, which could act as an optimal contender for sensitive in vivo tumor imaging with outstanding targeting ability.

Surface Design of Eu-Doped Iron Oxide Nanoparticles for Tuning the Magnetic Relaxivity

Relaxivity tuning of nanomaterials with the intrinsic T₁- T₂ dual-contrast ability has great potential for MRI applications. Until now, the relaxivity tuning of T₁ and T₂ dual-modal MRI nanoprobes has been accomplished through the dopant, size, and morphology of the nanoprobes, leaving room for bioapplications. However, a surface engineering method for the relaxivity tuning was seldom reported. Here, we report the novel relaxivity tuning method based on the surface engineering of dual-mode T₁- T₂ MRI nanoprobes (DMNPs), along with protein interaction monitoring with the DMNPs as a potential biosensor application. Core nanoparticles (NPs) of europium-doped iron oxide (EuIO) are prepared by a thermal decomposition method. As surface materials, citrate (Cit), alendronate (Ale), and poly(maleic anhydride- alt-1-octadecene)/poly(ethylene glycol) (PP) are employed for the relaxivity tuning of the NPs based on surface engineering, resulting in EuIO-Cit, EuIO-Ale, and EuIO-PP, respectively. The key achievement of the current study is that the surface materials of the DMNP have significant impacts on the r₁ and r₂ relaxivities. The correlation between the hydrophobicity of the surface material and longitudinal relaxivity ( r₁) of EuIO NPs presents an exponential decay feature. The r₁ relaxivity of EuIO-Cit is 13.2-fold higher than that of EuIO-PP. EuIO can act as T₁- T₂ dual-modal (EuIO-Cit) or T₂-dominated MRI contrast agents (EuIO-PP) depending on the surface engineering. The feasibility of using the resulting nanosystem as a sensor for environmental changes, such as albumin interaction, was also explored. The albumin interaction on the DMNP shows both T₁ and T₂ relaxation time changes as mutually confirmative information. The relaxivity tuning approach based on the surface engineering may provide an insightful strategy for bioapplications of DMNPs and give a fresh impetus for the development of novel stimuli-responsive MRI nanoplatforms with T₁ and T₂ dual-modality for various biomedical applications.

Current progress in the controlled synthesis and biomedical applications of ultrasmall (<10 nm) NaREF4 nanoparticles

The design and fabrication of rare earth upconversion nanoparticle (UCNP)-based nanomedical platforms have evoked increasing interest. However, their bio-safety is always the most worrisome problem. Most nanoparticles can accumulate in the internal organs, leading to acute toxicity, a long-term inflammatory response, or even fibrosis and cancer. In contrast, ultrasmall (sub-10 nm) nanoparticles have minimal safety risk because they can escape from macrophages, pass biological barriers, and be easily degraded or excreted from the body. In this review, we mainly introduce new progress in preparation strategies, imaging and drug delivery with regards to ultrasmall UCNPs, with an emphasis on rare earth fluorides, NaREF₄. Finally, we discuss the future outlook and challenges relating to ultrasmall UCNPs.

Facile ex situ NaF size/morphology tuning strategy for highly monodisperse sub-5 nm β-NaGdF4:Yb/Er

A facile ex situ NaF size/morphology tuning strategy for NaF release rate regulation was presented and successfully used to achieve time-saving controlled solvothermal synthesis of highly monodisperse/crystalline sub-5 nm β-NaGdF₄:Yb/Er at a high growth temperature of 300 °C.

Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents

Magnetic resonance imaging (MRI) is a highly valuable non-invasive imaging tool owing to its exquisite soft tissue contrast, high spatial resolution, lack of ionizing radiation, and wide clinical applicability. Contrast agents (CAs) can be used to further enhance the sensitivity of MRI to obtain information-rich images. Recently, extensive research efforts have been focused on the design and synthesis of high-performance inorganic nanoparticle-based CAs to improve the quality and specificity of MRI. Herein, the basic rules, including the choice of metal ions, effect of electron motion on water relaxation, and involved mechanisms, of CAs for MRI have been elucidated in detail. In particular, various design principles, including size control, surface modification (e.g. organic ligand, silica shell, and inorganic nanolayers), and shape regulation, to impact relaxation of water molecules have been discussed in detail. Comprehensive understanding of how these factors work can guide the engineering of future inorganic nanoparticles with high relaxivity. Finally, we have summarized the currently available strategies and their mechanism for obtaining high-performance CAs and discussed the challenges and future developments of nanoparticulate CAs for clinical translation in MRI.

Perylene Diimide-Grafted Polymeric Nanoparticles Chelated with Gd3+ for Photoacoustic/T1-Weighted Magnetic Resonance Imaging-Guided Photothermal Therapy

Developing versatile and easily prepared nanomaterials with both imaging and therapeutic properties have received significant attention in cancer diagnostics and therapeutics. Here, we facilely fabricated Gd³⁺-chelated poly(isobutylene-alt-maleic anhydride) (PMA) framework pendent with perylene-3,4,9,10-tetracarboxylic diimide (PDI) derivatives and poly(ethylene glycol) (PEG) as an efficient theranostic platform for dual-modal photoacoustic imaging (PAI) and magnetic resonance imaging (MRI)-guided photothermal therapy. The obtained polymeric nanoparticles (NPs) chelated with Gd³⁺ (PMA-PDI-PEG-Gd NPs) exhibited a high T₁ relaxivity coefficient (13.95 mM^-1 s^-1) even at the higher magnetic fields. After 3.5 h of tail vein injection of PMA-PDI-PEG-Gd NPs, the tumor areas showed conspicuous enhancement in both photoacoustic signal and T₁-weighted MRI intensity, indicating the efficient accumulation of PMA-PDI-PEG-Gd NPs owing to the enhanced permeation and retention effect. In addition, the excellent tumor ablation therapeutic effect in vivo was demonstrated with living mice. Overall, our work illustrated a straightforward synthetic strategy for engineering multifunctional polymeric nanoparticles for dual-modal imaging to obtain more accurate information for efficient diagnosis and therapy.

Design of Optimally Stable Molecular Coatings for Fe-Based Nanoparticles in Aqueous Environments

Magnetic nanoparticles are widely used in biomedical and oil-well applications in aqueous, often harsh environments. The pursuit for high-saturation magnetization together with high stability of the molecular coating that prevents agglomeration and oxidation remains an active research area. Here, we report a detailed analysis of the criteria for the stability of molecular coatings in aqueous environments along with extensive first-principles calculations for magnetite, which has been widely used, and cementite, a promising emerging candidate. A key result is that the simple binding energies of molecules cannot be used as a definitive indicator of relative stability in a liquid environment. Instead, we find that H⁺ ions and water molecules facilitate the desorption of molecules from the surface. We further find that, because of differences in the geometry of crystal structures, molecules generally form stronger bonds on cementite surfaces than they do on magnetite surfaces. The net result is that molecular coatings of cementite nanoparticles are more stable. This feature, together with the better magnetic properties, makes cementite nanoparticles a promising candidate for biomedical and oil-well applications.

Renal Clearable Peptide Functionalized NaGdF4 Nanodots for High-Efficiency Tracking Orthotopic Colorectal Tumor in Mouse

The effective delivery of bioimaging probes to a selected cancerous tissue has extensive significance for biological studies and clinical investigations. Herein, the peptide functionalized NaGdF₄ nanodots (termed as, pPeptide-NaGdF₄ nanodots) have been prepared for highly efficient magnetic resonance imaging (MRI) of tumor by formation of Gd-phosphonate coordinate bonds among hydrophobic NaGdF₄ nanodots (4.2 nm in diameter) with mixed phosphorylated peptide ligands including a tumor targeting phosphopeptide and a cell penetrating phosphopeptide. The tumor targeting pPeptide-NaGdF₄ nanodots have paramagnetic property with ultrasmall hydrodynamic diameter (HD, c.a., 7.3 nm) which greatly improves their MRI contrast ability of tumor and facilitates renal clearance. In detail, the capability of the pPeptide-NaGdF₄ nanodots as high efficient contrast agent for in vivo MRI is evaluated successfully through tracking small drug induced orthotopic colorectal tumor (c.a., 195 mm³ in volume) in mouse.

Sequential growth of CaF2:Yb,Er@CaF2:Gd nanoparticles for efficient magnetic resonance angiography and tumor diagnosis

It is a significant challenge to develop nanoscale magnetic resonance imaging (MRI) contrast agents with high performance of relaxation.